Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

Hepatology

Volumn 37, Issue 5, 2003, Pages 1180-1188

  Zhu, Haizhen ^a   Zhao, Hongshan ^a   Collins, Christin D ^b   Eckenrode, Sarah E ^b   Run, Qingguo ^b   McIndoe, Richard A ^b   Crawford, James M ^a   Nelson, David R ^a   She, Jin Xiong ^b   Liu, Chen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; COMPLEMENTARY DNA; GENOMIC RNA; STAT3 PROTEIN; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA MICROARRAY; DNA RESPONSIVE ELEMENT; DRUG EFFICACY; DRUG MECHANISM; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REPLICON; RNA REPLICATION; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS REPLICATION;

EID: 0038185313     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50184     Document Type: Article

References (36)

1. Theodore D, Fried MW. Natural history and disease manifestations of hepatitis C infection. Curr Top Microbiol Immunol 2000;242:43-54.
2. Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 2001;313:451-464.
3. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. HEPATOLOGY 1999;30:595-601.
4. Davis GL. Combination treatment with interferon and ribavirin for chronic hepatitis C. Clin Liver Dis 1999;3:811-826.
5. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling MH, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002;122:1303-1313.
6. Biron CA. Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin Immunol 1998;10:383-390.
7. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984;38:745-755.
8. Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002;2:675-687.
9. Gale M Jr, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 1998;18:5208-5218.
10. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein [Comments]. Science 1999;285:107-110.
11. Pflugheber J, Fredericksen B, Sumpter R Jr, Wang C, Ware F, Sodora DL, Gale M Jr. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc Natl Acad Sci U S A 2002;99:4650-4655.
12. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999;285:110-113.
13. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000;290:1972-1974.
14. Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis c virus replicon. J Virol 2001;75:8516-8523.
15. Ikeda M, Yi M, Li K, Lemon SM. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 2002;76:2997-3006.
16. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868.
17. Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 2001;75:1252-264.
18. Mottola G, Cardinali G, Ceccacci A, Trozzi C, Bartholomew L, Torrisi MR, Pedrazzini E, et al. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing vital subgenomic replicons. Virology 2002;293:31-43.
19. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
20. Tian Z, Shen X, Feng H, Gao B. IL-1 β attenuates IFN-α β-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J Immunol 2000;165:3959-3965.
21. Ichikawa T, Nakao K, Nakata K, Yamashita M, Hamasaki K, Shigeno M, Abiru S, et al. Involvement of IL-1β and IL-10 in IFN-α-mediated antiviral gene induction in human hepatoma cells. Biochem Biophys Res Commun 2002;294:414-422.
22. Stark GR, Kerr IM, Williams BR, Silvetman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-264.
23. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci U S A 1998;95:15623-15628.
24. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001;69:912-920.
25. Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001;75:7059-7066.
26. Lanford RE, Bigger C, Bassett S, Klimpel G. The chimpanzee model of hepatitis C virus infections. Ilar J 2001;42:117-126.
27. Kelly JM, Porter AC, Chernajovsky Y, Gilbert CS, Stark GR, Kerr IM. Characterization of a human gene inducible by α- and β-interferons and its expression in mouse cells. EMBO J 1986;5:1601-1606.
28. Clauss IM, Wathelet MG, Szpirer J, Content J, Islam MQ, Levan G, Szpirer C, et al. Chromosomal localization of two human genes inducible by interferons, double-stranded RNA, and viruses. Cytogenet Cell Genet 1990;53:166-168.
29. Porter AC, Chernajovsky Y, Dale TC, Gilbert CS, Stark GR, Kerr IM. Interferon response element of the human gene 6-16. EMBO J 1988;7:85-92.
30. Nguyen VA, Chen J, Hong F, Ishac EJ, Gao B. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism. Biochem J 2000;349:427-434.
31. Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, et al. Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 2002;122:1020-1034.
32. Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. Interferon α/β promotes cell survival by activating nuclear factor κ B through phospharidylinositol 3-kinase and Akt. J Biol Chem 2001;276:13756-13761.
33. Yang CH, Shi W, Basu L, Murti A, Consrantinescu SN, Blatr L, Croze E, et al. Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J Biol Chem 1996;271:8057-8061.
34. Yang CH, Murti A, Pfeffer LM. STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc Nad Acad Sci U S A 1998;95:5568-5572.
35. Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κ B. Proc Nad Acad Sci U S A 2001;98:9599-9604.
36. Fredericksen B, Akkaraju GR, Foy E, Wang C, Pflugheber J, Chen ZJ, Gale M Jr. Activation of the interferon-β promoter during hepatitis C virus RNA replication. Viral Immunol 2002;15:29-40.